Rare diseases
Investigational molecules
Locations
Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BulgariaA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
BulgariaA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
BulgariaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
BulgariaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
BulgariaA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
BulgariaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
